Schneider Electric has secured an $11.5 million contract with the Child and Adolescent Health Service for a technology package at the Perth Children's Hospital.
Researchers at Telethon Kids and Harry Perkins institutes have been awarded more than $18 million in funding for health and medical research from both state and federal governments.
Shares in digital health company ResApp Health have closed up 33 per cent today to 20 cents, after it received European regulatory approval for its first commercial product – the ResAppDx-EU.
HBF has sold the Friendlies Pharmacy master franchise, under which 31 Western Australian pharmacies currently operate, to Pharmacy 777 and agreed to partner with the buyer to provide preventative health services to its members across the stores.
St John of God Health Care is partnering with GenesisCare and national medical property development group Heathley to deliver a $17 million comprehensive cancer centre at Murdoch.
A medical startup supported by Curtin University and angel investors led by Ian Brown has raised more than $1 million, shining a light on the commercialisation process for university technology.
Botanix Pharmaceuticals is set to raise $40 million via a share placement, less than two months after it released studies suggesting its cannabis compound could be used as an antimicrobial to mitigate superbugs.
For Kerryn Ashford-Hatherly and Michael Tunnecliffe, principal psychologists at West Perth-based Ashcliffe Psychology, treating addiction is about restoring order to chaotic lives.
Fifteen businesses have expressed an interest in buying Berrington Care Group, an aged care provider which went into administration earlier this month, while residents consider options for nearly $125 million of deposits.
The state government has started the expressions of interest process for the Osborne Park Hospital expansion, which includes a new neonatal nursery, a maternity assessment unit and a 16-bed rehabilitation unit.
International medical services company B.Braun has secured a $44.2 million state government contract for the supply of volumetric infusion pumps and administration sets to Western Australian public healthcare units.
Cancer-focused medical technology company BARD1 Life Sciences has raised around $7.5 million via a share placement and rights issue, and has appointed two non-executive directors to its board.
Gary Lee has dedicated his professional life to making it easier for people to breathe, and on Friday night he was recognised for his work at the annual Cancer Council WA awards.
Western Australians are putting their bodies on the line to provide vital funds for some of the state’s most active medical charities and research organisations.